Pharmacogenetic testing: Legal considerations for consent, privacy and disclosure

Personalized Medicine

Volumn 5, Issue 2, 2008, Pages 155-161

  Romeo Malanda, Sergio ^a   Nicol, Dianne ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Consent; Disclosure; Duty of confidentiality; Exceptional circumstances; Pharmacogenetic testing; Right to privacy

Indexed keywords

CONFIDENTIALITY; EUROPE; GENETIC ANALYSIS; HUMAN RIGHTS; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; LAW; LEGAL ASPECT; LEGAL LIABILITY; PHARMACOGENETICS; PRIORITY JOURNAL; PRIVACY; PROFESSIONAL SECRECY; REVIEW;

EID: 42549168089     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/17410541.5.2.155     Document Type: Review

References (21)

1. Ethical, Legal and Social Aspects of Genetic Testing Research Development and Clinical Applications. Independent Expert Group on Genetic Data, European Commission. Brussels (2004).
2. Buchanan A, Califano A, Kahn F, McPherson E, Robertson J. Brody B: Pharmacogenetics: ethical issues and policy options. Kennedy Inst. Ethics J. 12(1), 1-15 (2002).
3. Robertson JA: Consent and privacy in pharmacogenetic testing. Nat. Genet. 28, 207-209 (2001).
4. Roses AD: Pharmacogenetics and the practice of medicine. Nature 405, 857-865 (2000).
5. Bellver-Capella V: Ética, politica y derechos en farmacogenética. Law Hum, Genome Rev. 17, 31-55 (2002).
6. Hedgecoe A: The Politics of Personalised Medicine: Pharmacogenetics in the Clinic. Cambridge University Press, Cambridge, UK (2004).
7. Brice P, Sanderson S: Pharmacogenetics: what are the ethical and economic Implications? Pharmacogenomics J. 277, 113-114 (2006).
8. Vaszar LT, Rosen GD. Raffin TA: Pharmacogenomics and the challenge to privacy. Pharmacogenomics J. 2, 144-147 (2000).
9. Ruiz-Canela López M: Pharmacogenomics: a new challenge for the ethics of research. Sociedad Internacional de Bioética, Gijón. Spain (2004).
10. de Sola C: Privacy and genetic data. Cases of conflict (I). Law Hum. Genome Rev. 1, 173-184 (1994).
11. Freire Falcâo de Oliveira G: Juridical implications of genome knowledge (II). Law Hum. Genome Rev. 7, 59-98 (1997).
12. Kriari-Catranis I: Genetic data and confidentiality, the Estonian experiment. Law Hum. Genome Rev. 19, 147-157 (2003).
13. Romeo-Malanda S, Nicol D: Protection of genetic data in medical genetics: a legal analysis in the European context. Law Hum. Genome Rev. 27, 97-134 (2007).
14. Skene L: Law and Medical Practice: Rights, Duties, Claims and Defences (Second Edition). LexisNexis Butterworths, Sydney, Australia (2004).
15. Romeo-Casabona CM: Anonymization and pseudonymization: the legal framework at a European level. In: The Data Protection Directive and Medical Researrh Across Europe. Beyleveld D, Townend D, Rouillé-Mirza S, Wright J (Eds). Ashgate, UK, 33-49 (2004).
16. Nicolás-Jiménez P: La Protección Jurídica de los Datos Genéticos de Carácter Personal. Cátedra Interuniversitaria de Derecho y Genoma Humano-Comares, Bilbao-Granada, Spain (2006).
17. Working Document on Genetic Data. Data Protection Working Party, European Commission (2004).
18. Romeo-Casabona CM: Genetic information: collection, access and use. In: Frontiers of Life, Volume IV: The Living World. Academic Press, CA, USA, 777-789 (2001).
19. Roscam Abbing HDC: Genetic information and third party interests. How to find the right balance? Law Hum. Genome Rev. 2, 35-52 (1995).
20. Pharmacogenetics: Ethical Issues. Nuffield Council on Bioethics, London, UK (2003).
21. Nys H, Romeo-Casabona CM, Desmet C: Legal aspects of prenatal testing for late-onset neurological diseases. In: Prenatal Testing For Late-Onset Neurological Diseases. Evers-Kiebooms G, Zoetewelj MW, Harper PS (Eds). Routledge, London, UK, 83-106 (2002).